 NEW YORK--BUSINESS WIRE--CM Life Sciences, Inc. NASDAQ:CMLF today announced that it has filed with the Securities and Exchange Commission SEC an amended annual report on Form 10-KA and a Form 8-K reporting the restatement of certain of its previously issued financial statements. The restatement was following a statement issued on April 12, 2021 by the Acting Director of the Division of Corporation Finance and the Acting Chief Accountant of the SEC relating to reporting considerations for 